Cargando…
PSMA PET imaging in the diagnosis and management of prostate cancer
Prostate cancer is the second leading cause of cancer-related deaths in men in the United States. Imaging techniques such as CT, MRI, and bone scans have traditionally been used for diagnosis and staging. Molecular imaging modalities targeting the prostate-specific membrane antigen (PSMA) have recen...
Autores principales: | Houshmand, Sina, Lawhn-Heath, Courtney, Behr, Spencer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682054/ https://www.ncbi.nlm.nih.gov/pubmed/37493837 http://dx.doi.org/10.1007/s00261-023-04002-z |
Ejemplares similares
-
FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008) -
A pictoral review on somatostatin receptor scintigraphy in neuroendocrine tumors: The role of multimodality imaging with SRS and GLUT receptor imaging with FDG PET-CT
por: Shah, Sneha, et al.
Publicado: (2012) -
FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013) -
Pictorial essay: PET/CT in tuberculosis
por: Harkirat, S, et al.
Publicado: (2008) -
Gallium-68 prostate-specific membrane antigen ([(68)Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study
por: Lawhn-Heath, Courtney, et al.
Publicado: (2020)